Figure 3

Changes in plasma renin activity and aldosterone levels between aliskiren group (solid bars) and calcium channel blocker (CCB) group (open bars). *P<0.01, **P<0.001 vs. baseline.

Changes in plasma renin activity and aldosterone levels between aliskiren group (solid bars) and calcium channel blocker (CCB) group (open bars). *P<0.01, **P<0.001 vs. baseline.